Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer

Oncology Reports
Yifan LiYongqing Lai

Abstract

Renal cell carcinoma (RCC) is the most common kidney cancer in adults and has a poor prognosis. cAMP responsive element binding protein 1 (CREB1) is a proto‑oncogenic transcription factor involved in malignancies of various organs. However, its functional role(s) have not yet been elucidated in RCC. We investigated the expression pattern, function and regulation of CREB1 in RCC. CREB1 was overexpressed in the RCC tissues and cell lines. Downregulation of CREB1 inhibited RCC tumorigenesis by affecting cell proliferation, migration and apoptosis. Multiple computational algorithms predicted that the 3'‑untranslated region (3'‑UTR) of human CREB1 mRNA is a target for miR‑10b‑5p and miR‑363‑3p. Luciferase reporter assay, qPCR and western blot analysis confirmed that miR‑10b‑5p and miR‑363‑3p bind directly to the 3'‑UTR of CREB1 mRNA and inhibit mRNA and protein expression of CREB1. qPCR data also revealed a significantly lower expression of miR‑10b‑5p and miR‑363‑3p in RCC tissues. Introduction of miR‑10b‑5p and miR‑363‑3p mimics led to suppressed expression of CREB1 and inhibited cell proliferation, migration and apoptosis reduction. Taken together, we propose that CREB1 is an oncogene in RCC and that upregulation of CREB1 by loss ...Continue Reading

References

Jul 1, 1990·Genomics·A K TaylorA J Lusis
Sep 19, 1996·The New England Journal of Medicine·R J MotzerD M Nanus
Aug 3, 2001·Nature Reviews. Molecular Cell Biology·B Mayr, M Montminy
Mar 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xinmin ZhangMarc Montminy
Apr 20, 2005·Cancer Cell·Deepa B ShankarKathleen M Sakamoto
Jul 4, 2006·DNA Repair·Siegfried Janz
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina R AntonescuMarc Ladanyi
Dec 26, 2006·Cancer Letters·Karolin H HallorIoannis Panagopoulos
Jun 15, 2007·The FEBS Journal·Yeung-Tung Siu, Dong-Yan Jin
Feb 26, 2009·Cell·Richard W Carthew, Erik J Sontheimer
Mar 5, 2009·Cancer Research·Martina PigazziGiuseppe Basso
Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathleen M Sakamoto, David A Frank
Oct 10, 2009·The American Journal of Pathology·Arti ShuklaBrooke T Mossman
Nov 19, 2009·Journal of Cancer Research and Clinical Oncology·Zhengjun YiChuanxiang Ma
Dec 22, 2009·The Journal of Urology·Tsz-Fung F ChowGeorge M Yousef
Dec 29, 2009·Urology·David JuanLouis S Liou
Jul 28, 2010·Nature Reviews. Genetics·Jacek KrolWitold Filipowicz
Jan 20, 2011·Nature Reviews. Genetics·Eric Huntzinger, Elisa Izaurralde
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jul 4, 2012·Seminars in Cancer Biology·Eamonn R Maher
Sep 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xiaochao TanXiaozhong Peng
Dec 19, 2012·The International Journal of Biochemistry & Cell Biology·Qiang SunWantao Chen
Feb 8, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Han HanYoujun Li
Apr 2, 2013·Molecular and Cellular Biochemistry·Biao PengDan Li
Jan 8, 2014·Experimental Cell Research·Molin LiChuangang Li
Mar 7, 2014·Seminars in Interventional Radiology·Carole A RidgeDavid C Madoff

❮ Previous
Next ❯

Citations

Apr 1, 2017·Journal of Clinical Pathology·Heba W Z KhellaGeorge M Yousef
Apr 17, 2019·Oncology Letters·Jessica CarlssonPernilla Sundqvist
Jul 3, 2020·Scientific Reports·Siri H StrandKarina Dalsgaard Sørensen
Jun 6, 2018·Nature Reviews. Urology·Sophie C JoostenManon van Engeland
Jan 27, 2019·Investigative Ophthalmology & Visual Science·Colleen M CebullaMohamed H Abdel-Rahman
Oct 21, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Su DongJia Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis